Catalyst Wire Dossier Catalyst Wire Dossier

Elexacaftor combination therapy

elexacaftor/tezacaftor/ivacaftor · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elexacaftor combination therapy, covering 2023-07-28 to 2023-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy [Phase 3]

See pricing